Articles

WellPoint profit better than analyst estimates

Excluding special charges, WellPoint’s profit fell 2 percent to $524.7 million in the fourth quarter from $536 million in the fourth quarter of 2009. But earnings per share improved thanks to stock buybacks.

Read More

Endocyte prices IPO stock

The West Lafayette-based drug development firm intends to sell 6.15 million shares for $13 to $15 apiece. That would fetch $80 million to $92 million.

Read More

Interactive Intelligence expecting strong earnings

Indianapolis-based business-communications software firm said it is expecting higher profit and revenue for both the fourth quarter and fiscal 2010. Lucrative product orders in the fourth quarter should help boost earnings.

Read More

Roche aims to prevent bidding war for software firm

The Swiss company, which operates its North American business out of Indianapolis, filed a lawsuit late last month against Virginia-based Medical Automation Systems Inc. for breaching the purchase agreement the companies signed back in October.

Read More

HHGregg shares slide on lower earnings outlook

The Indianapolis-based appliance and electronics retailer attributed its lower outlook to weak demand for new video technology products. Sales of LED and 3-D televisions were less than expected while sales of lower-priced TVs were higher than anticipated.

Read More

Emmis pitching in on breach-of-contract lawsuit

Emmis Communications Corp. will contribute $200,000 toward legal fees in a lawsuit that company founder Jeff Smulyan’s JS Acquisition LLC filed over its failed effort to take the Indianapolis-based media company private.

Read More

Amylin and Lilly seek expanded Byetta approval

Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Wednesday they are asking the Food and Drug Administration to expand approval for their type 2 diabetes drug Byetta, which could bolster sales as the companies try to get approval for a new, longer-lasting version of the drug.

Read More